New Zealand markets close in 4 hours 7 minutes

Genflow Biosciences plc (GENF.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
1.6250+0.0750 (+4.84%)
At close: 02:38PM BST
Currency in GBp

Valuation measures4

Market cap (intra-day) 5.42M
Enterprise value 3.91M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)3.15
Enterprise value/revenue N/A
Enterprise value/EBITDA -3.31

Trading information

Stock price history

Beta (5Y monthly) 2.47
52-week change 3-63.10%
S&P500 52-week change 322.64%
52-week high 34.4000
52-week low 30.0000
50-day moving average 31.5077
200-day moving average 31.7549

Share statistics

Avg vol (3-month) 3930.86k
Avg vol (10-day) 31.04M
Shares outstanding 5349.71M
Implied shares outstanding 6349.71M
Float 8132.69M
% held by insiders 163.66%
% held by institutions 19.15%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Jun 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-320.20%

Management effectiveness

Return on assets (ttm)-30.00%
Return on equity (ttm)-51.61%

Income statement

Revenue (ttm)194.07k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-1.18M
Diluted EPS (ttm)-0.0000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.51M
Total cash per share (mrq)0
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)9.83
Book value per share (mrq)0.01

Cash flow statement

Operating cash flow (ttm)-1.43M
Levered free cash flow (ttm)-959.4k